Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ASA physical status of I to III scheduled for elective laparoscopic cholecystectomy with BMI 18 to 30kg per meter Squuare.
Exclusion criteria
Exclusion criteria: 1.Infection at the injection site or systemic sepsis. 2.Known allergy to local anaesthetics such as bupivacaine. 3.Coagulopathy or anticoagulation therapy. 4.Chronic pain or pre-existing opioid tolerance. 5.Specific to Biomarkers History of endocrine disorders such as Cushing, Addison, or Diabetes Mellitus or use of steroids, as these significantly interfere with glucose levels.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Intensity: NRS from 0 (no pain) to 10 (worst pain).Timepoint: Measurements are taken at rest and during movement (coughing) at specific intervals: 2, 4, 6, 12, and 24 hours postoperatively. | — |
Secondary
| Measure | Time frame |
|---|---|
| Stress Biomarkers: 1.NLR: Measured via venous blood samples at T0 (baseline, pre-induction), T1 (6 hours postoperatively), and T2 (24 hours postoperatively). 2.Blood Glucose: Collected at the same time points. 3.PLR: Collected at the same time points. Analgesic Consumption: Total 24-hour tramadol consumption Side Effects: Monitoring PONV, pruritus, shoulder pain or respiratory depression. Timepoint: Stress Biomarkers: 1.NLR: Measured via venous blood samples at T0 (baseline, pre-induction), T1 (6 hours postoperatively), and T2 (24 hours postoperatively). 2.Blood Glucose: Collected at the same time points. 3.PLR: Collected at the same time points. Analgesic Consumption: Total 24-hour tramadol consumption Side Effects: Monitoring PONV, pruritus, shoulder pain or respiratory depression. | — |
Countries
India
Contacts
Government Institute of Medical Sciences(GIMS)